Article Information
History
- December 6, 2024.
Article Versions
- Version 1 (August 9, 2024 - 12:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ciarrah-Jane S Barrya,b,*,
- Venexia M Walkera,b,c,
- Christy Burdend,
- George Davey Smitha,b and
- Neil M Daviese,f,g
- aMedical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, BS82BN, UK
- bPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS82BN, UK
- cDepartment of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
- dTranslational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- eK.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
- fDivision of Psychiatry, University College London, London, UK
- gDepartment of Statistical Science, University College London, London, UK
- ↵*Corresponding author: Ciarrah-Jane S Barry (ciarrah.barry{at}bristol.ac.uk), +44 (0)117 331 0098
Posted December 06, 2024.
Assessing the benefits and risks to mothers and offspring of continuing treatment for maternal hypertension and hypothyroidism: an observational cohort study in the UK Clinical Practice Research Datalink
